(Q38309812)

2 September 2017

RalA regulates vascular endothelial growth factor-C (VEGF-C) synthesis in prostate cancer cells during androgen ablation (English)

1 reference

2 September 2017

0 references

1 reference

Rinaldo F

1

1 reference

2 September 2017

Li J

2

1 reference

2 September 2017

Wang E

3

1 reference

2 September 2017

Muders M

4

1 reference

2 September 2017

Datta K

5

1 reference

2 September 2017

language of work or name

English

0 references

publication date

11 September 2006

1 reference

2 September 2017

1 reference

2 September 2017

26

1 reference

2 September 2017

12

1 reference

2 September 2017

1731-1738

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209971

2 September 2017

0 references

cites work

RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

Enhanced cathepsin L expression is mediated by different Ras effector pathways in fibroblasts and epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

Ras-dependent regulation of c-Jun phosphorylation is mediated by the Ral guanine nucleotide exchange factor-Ral pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

Ral-GTPases: approaching their 15 minutes of fame

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

The biology of hormone refractory prostate cancer. Why does it develop?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

Expression of vascular endothelial growth factor-C and the relationship between lymphangiogenesis and lymphatic metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

Upregulation of VEGF-C by androgen depletion: the involvement of IGF-IR-FOXO pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

Androgenic regulation of oxidative stress in the rat prostate: involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

The small G-protein RalA stimulates metastasis of transformed cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

7 January 2021

Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

7 January 2021

Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

7 January 2021

MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER: CURRENT STANDARDS AND FUTURE PROSPECTS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

7 January 2021

Lymphatic vessel density and lymph node metastasis in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209971

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209971

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference